Strive is linked to a fund that targets 2 times ASST’s daily move. The story reports no change to Strive’s business, so its outlook is unchanged.
The fund gives investors another way to take a larger daily position in ASST. But the story gives no evidence of added sales, fees, or other business gains for Strive. The warning about compounding concerns fund holders, not a reported change at Strive.
Global X recently launched an ETF focused on AI language-model companies. The story gives no sales or investor-demand figures for the fund, so it does not show a change in Global X’s outlook.
Amplify’s ETF offers concentrated exposure to semiconductor stocks. The story gives no investor-demand figures or effect on Amplify’s business, so it does not change the company’s outlook.
Follow Strive Inc. (ASST) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ASST